The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 3-(Di-2-thienylmethylene)-5-methoxy-1,1-dimethyl-piperidinium bromide Drug Master File in Japan (3-(Di-2-thienylmethylene)-5-methoxy-1,1-dimethyl-piperidinium bromide JDMF) empowers 3-(Di-2-thienylmethylene)-5-methoxy-1,1-dimethyl-piperidinium bromide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 3-(Di-2-thienylmethylene)-5-methoxy-1,1-dimethyl-piperidinium bromide JDMF during the approval evaluation for pharmaceutical products. At the time of 3-(Di-2-thienylmethylene)-5-methoxy-1,1-dimethyl-piperidinium bromide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 3-(Di-2-thienylmethylene)-5-methoxy-1,1-dimethyl-piperidinium bromide suppliers with JDMF on PharmaCompass.